Economic Insight is advising a large manufacturer of generic pharmaceuticals in relation to a claim for damages caused by a delay to market entry, which is to be heard at the High Court.
Economic Insight is advising a large manufacturer of generic pharmaceuticals in relation to a claim for damages caused by a delay to market entry, which is to be heard at the High Court.